Clinical Trial: Furosemide vs Placebo in Severe Preeclampsia Postpartum

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07648251) titled 'Furosemide vs Placebo in Severe Preeclampsia Postpartum' on June 09.

Brief Summary: This randomized, double-blind, placebo-controlled trial evaluates whether oral furosemide 40 mg, initiated 12 hours postpartum, reduces hospital length of stay compared to placebo (folic acid 5 mg) in postpartum women with severe preeclampsia. Secondary outcomes include need for rescue antihypertensive medications, weight reduction, and metabolic safety (hypokalemia, renal function). A total of 186 participants (93 per arm) will be enrolled across two hospitals in Honduras.

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Severe Pr...